Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

KOSDAQ:A108490
KOSDAQ:A108490Electronic

High Growth Tech Stocks in Asia with Promising Potential

Amidst a backdrop of global market volatility and geopolitical uncertainties, the Asian tech sector continues to capture investor interest with its dynamic growth potential. As we explore three high-growth tech stocks in Asia, it's essential to consider factors such as innovation, scalability, and adaptability to shifting economic conditions that can drive long-term success in this rapidly evolving landscape.
SGX:T6I
SGX:T6IConsumer Finance

Uncovering Asia's Undiscovered Gems This January 2026

As we enter January 2026, Asian markets are navigating a landscape marked by mixed economic indicators and geopolitical uncertainties, with key indices reflecting both challenges and opportunities. In this dynamic environment, identifying promising small-cap stocks requires a keen understanding of market conditions and the ability to spot companies that demonstrate resilience and growth potential amidst broader volatility.
ENXTAM:APAM
ENXTAM:APAMMetals and Mining

Does Aperam’s New “Slink” Motor-Alloy Breakthrough Reshape The Bull Case For Aperam (ENXTAM:APAM)?

In January 2026, Aperam announced its new "slink" production method, adapting in-plane helical bending to iron-cobalt alloys to manufacture stators and rotors more efficiently and with sharply reduced material waste for high-performance electric motors. By pairing the "slink" process with its AFK iron-cobalt alloys, Aperam is opening new design options for electric propulsion in aviation, eVTOL aircraft, and hypercars while supporting more sustainable use of high-cost materials. We’ll now...
NYSE:LHX
NYSE:LHXAerospace & Defense

L3Harris Technologies (LHX) Net Margin Steady At 7.3% Reinforces Measured Bullish Narratives

L3Harris Technologies (LHX) closed out FY 2025 with fourth quarter revenue of US$5.6b and basic EPS of US$1.60, alongside net income of US$300m, while trailing twelve month EPS stood at US$8.57 on revenue of US$21.9b and net income of US$1.6b. Over the past six quarters, the company has seen quarterly revenue move from US$5.3b in Q3 2024 to US$5.6b in Q4 2025, with basic EPS ranging between US$1.60 and US$2.47 and net income between US$300m and US$462m, setting a clear earnings profile for...
NYSE:SHW
NYSE:SHWChemicals

Sherwin Williams (SHW) Margin Compression Challenges Premium 34x P E Narrative

Sherwin-Williams (SHW) has wrapped up FY 2025 with fourth quarter revenue of US$5,595.9 million and basic EPS of US$1.94, alongside trailing twelve month revenue of US$23.6 billion and EPS of US$10.37 that frame the full year earnings picture. Over recent periods, revenue has moved from US$5,297.2 million in Q4 2024 to US$5,595.9 million in Q4 2025, while quarterly EPS has been reported at US$1.92 and US$1.94 respectively, giving investors a clear read on how top line and per share profits...
NasdaqGS:FFBC
NasdaqGS:FFBCBanks

First Financial Bancorp (FFBC) Earnings Growth Acceleration Challenges Cautious Narratives

First Financial Bancorp (FFBC) closed out FY 2025 with fourth quarter revenue of US$228.7 million and EPS of US$0.65. Trailing twelve month revenue was US$861.8 million and EPS was US$2.68. Over the past year, the company’s revenue increased from US$756.1 million to US$861.8 million and EPS moved from US$2.42 to US$2.68. This coincided with earnings growth of 11.7% over the last 12 months, compared with a 5-year average of 6.8% per year. Investors may weigh this growth and a 3.47% dividend...
NasdaqCM:SKYT
NasdaqCM:SKYTSemiconductor

IonQ SkyWater Deal Puts Quantum Ambitions And Shareholder Value Under Review

IonQ has entered a definitive agreement to acquire SkyWater Technology (NasdaqCM:SKYT), aiming to build a vertically integrated full stack quantum and semiconductor platform in the United States. The combined company is expected to focus on quantum chip development and manufacturing capabilities for government and commercial customers. Multiple law firms have launched investigations into whether the transaction terms and process are fair to SkyWater shareholders. For you as an investor,...
NYSE:JBL
NYSE:JBLElectronic

Is It Too Late To Consider Jabil (JBL) After Its Strong Multi Year Rally?

If you are wondering whether Jabil's share price still offers value, or if most of the opportunity is already reflected in the stock, this article walks through what the numbers indicate about where the price stands today. The stock last closed at US$243.92, with returns of 5.3% over 30 days, 1.5% year to date, 50.2% over 1 year, a gain of about 3x over 3 years, and an even larger gain over 5 years. Recent coverage has focused on Jabil's positioning in electronics manufacturing and supply...
NasdaqGS:HWBK
NasdaqGS:HWBKBanks

Hawthorn Bancshares (HWBK) Margin Improvement To 29.8% Tests Cautious Earnings Narratives

Hawthorn Bancshares (HWBK) has wrapped up FY 2025 with fourth quarter revenue of US$20.8 million and EPS of US$0.90, set against trailing 12‑month revenue of US$79.9 million and EPS of US$3.44 that came with 30.4% earnings growth over the past year. The company has seen revenue move from US$71.9 million and EPS of US$2.61 on a trailing basis a year ago to the latest US$79.9 million and US$3.44, while quarterly revenue has ranged between US$16.7 million and US$20.8 million through 2025. With...
NasdaqCM:FMNB
NasdaqCM:FMNBBanks

A Look At Farmers National Banc (FMNB) Valuation After Recent Share Price Weakness

Farmers National Banc (FMNB) is back on investors’ radar after recent share price moves, with the stock closing at $12.85 and showing mixed returns over the past week, month, and past 3 months. See our latest analysis for Farmers National Banc. At a share price of $12.85, Farmers National Banc has seen short term weakness, with a 7 day share price return of a 7.62% decline, while longer term total shareholder returns over three and five years sit at 2.99% and 14.51% respectively. This may...
NasdaqGS:IONS
NasdaqGS:IONSBiotechs

Has Ionis Pharmaceuticals (IONS) Run Too Far After Its 152% One Year Surge?

If you are wondering whether Ionis Pharmaceuticals at US$83.88 is starting to look expensive or still offers value, you are not alone. The stock has returned 2.6% over the last 7 days, 6.2% over 30 days, 5.3% year to date and 151.7% over the past year, with 103.6% over 3 years and 41.2% over 5 years, which will naturally shape how investors think about its risk and return profile. Recent coverage around Ionis has focused on its position in the pharmaceuticals and biotech space, where...